FSAD

(redirected from Female sexual arousal disorder)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Female sexual arousal disorder: Hypoactive sexual desire disorder, Sexual aversion disorder
AcronymDefinition
FSADFemale Sexual Arousal Disorder
FSADFoundation Studies in Art and Design (University of Gloucestershire; Cheltenham, UK)
FSADFiber Science & Apparel Design (course of study; Cornell University; Ithaca, NY)
FSADField-Safe Application Debugger
FSADFull Scale Advanced Development
FSADForce Structuring Analysis Division
References in periodicals archive ?
Innovus Pharma signed in May 2017 an exclusive license and distribution agreement with Luminarie, a company based in Australia, for the commercialization of Zestra for Female Sexual Arousal Disorder and Zestra Glide for female lubrication in the Australia, New Zealand and the Philippines.
Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double blind, placebo controlled study.
[8] (2011) No significant treatment effect of oral sildenafil for the treatment of female sexual arousal disorder as a result of spinal cord injury Lockhat et al.
The drug that treats erectile dysfunction in men is also being studied in clinical trials for female sexual arousal disorder. Some studies have found it may increase blood flow to the female genital area and increase relaxation of clitoral and vaginal muscles.
Flibanserin, a postsynaptic 5-HT(1A) agonist/5HT(2A) antagonist, has been studied in more than 10,000 women and shown to increase libido and response in those with female sexual arousal disorder (FSAD) and hypoactive sexual desire disorder (HSDD).